Details for 2020180938

Up to date per 03.04.2026

Actions

Title / Product Name

THERAPIEPLÄNE UND VERFAHREN ZUR BEHANDLUNG VON MULTIPLER SKLEROSE MITTELS OFATUMUMAB

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020180938

EP Publication Number

3733712

E-Number

1569453

Language

PCT Number

Publication Date

04.11.2020 A

24.05.2023 B1

Registration Date

24.05.2023

AT Publication Date

15.06.2023

Application Date

11.08.2017

Registration Number

Priorities

15.08.2016

201662374986 P

IPC

C07K 16/28 20060101AFI20201001BHEP

Maximum Duration of Protection

11.08.2037

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

WALLSTRÖM, Erikc/o Novartis Pharma AG Postfach 4002 BaselCH

SAVELIEVA PRAZ, Marinac/o Novartis Pharma AG Postfach 4002 BaselCH

KAKARIEKA WEISSKOPF, Algirdas Jonasc/o Novartis Pharma AG Postfach 4002 BaselCH

KAHN, Joseph Michaelc/o Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, NJ 07936-1080US

Information about Fees